miR-153 suppresses angiogenesis through targeting HIF1α as well as negative regulation of ANG1 and inhibition of endothelial cell tube formation and migration in breast cancer (Figure 3) (67, 80, 81). This evidence concerns the gene ANGPT1 and breast carcinoma.